U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C24H30N2O2.ClH
Molecular Weight 414.968
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DOXAPRAM HYDROCHLORIDE ANHYDROUS

SMILES

Cl.CCN1CC(CCN2CCOCC2)C(C1=O)(C3=CC=CC=C3)C4=CC=CC=C4

InChI

InChIKey=MBGXILHMHYLZJT-UHFFFAOYSA-N
InChI=1S/C24H30N2O2.ClH/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21;/h3-12,22H,2,13-19H2,1H3;1H

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
DOXAPRAM HYDROCHLORIDE ANHYDROUS
Common Name English
1-ETHYL-4-(2-MORPHOLINOETHYL)-3,3-DIPHENYL-2-PYRROLIDINONE HYDROCHLORIDE HYDRATE
Systematic Name English
2-PYRROLIDINONE, 1-ETHYL-4-(2-(4-MORPHOLINYL)ETHYL)-3,3-DIPHENYL-, MONOHYDROCHLORIDE, (±)-
Common Name English
2-PYRROLIDINONE, 1-ETHYL-4-(2-MORPHOLINOETHYL)-3,3-DIPHENYL-, MONOHYDROCHLORIDE, MONOHYDRATE
Common Name English
2-PYRROLIDINONE, 1-ETHYL-4-(2-(4-MORPHOLINYL)ETHYL)-3,3-DIPHENYL-, HYDROCHLORIDE, HYDRATE (1:1:1)
Systematic Name English
(±)-1-ETHYL-4-(2-MORPHOLINOETHYL)-3,3-DIPHENYL-2-PYRROLIDINONE MONOHYDROCHLORIDE
Systematic Name English
Code System Code Type Description
FDA UNII
FB8713U6DM
Created by admin on Fri Dec 15 16:31:46 UTC 2023 , Edited by admin on Fri Dec 15 16:31:46 UTC 2023
PRIMARY
CAS
113-07-5
Created by admin on Fri Dec 15 16:31:46 UTC 2023 , Edited by admin on Fri Dec 15 16:31:46 UTC 2023
PRIMARY
PUBCHEM
64647
Created by admin on Fri Dec 15 16:31:46 UTC 2023 , Edited by admin on Fri Dec 15 16:31:46 UTC 2023
PRIMARY
SMS_ID
100000087544
Created by admin on Fri Dec 15 16:31:46 UTC 2023 , Edited by admin on Fri Dec 15 16:31:46 UTC 2023
PRIMARY
ECHA (EC/EINECS)
204-022-3
Created by admin on Fri Dec 15 16:31:46 UTC 2023 , Edited by admin on Fri Dec 15 16:31:46 UTC 2023
PRIMARY
EPA CompTox
DTXSID9047837
Created by admin on Fri Dec 15 16:31:46 UTC 2023 , Edited by admin on Fri Dec 15 16:31:46 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of DOXAPRAM
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966